Related Experiment Video
Updated: May 26, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
EZH2 methyltransferase and H3K27 methylation in breast cancer
Kyung Hyun Yoo1, Lothar Hennighausen
1Laboratory of Genetics and Physiology, National Institutes of Health, Bethesda, MD 20892, USA. ryuk@mail.nih.gov
Abstract:
Histone modifications are thought to control the regulation of genetic programs in normal physiology and cancer. Methylation (mono-, di-, and tri-methylation) on histone H3 lysine (K) 27 induces transcriptional repression, and thereby participates in controlling gene expression patterns. Enhancer of zeste (EZH) 2, a methyltransferase and component of the polycomb repressive complex 2 (PRC2), plays an essential role in the epigenetic maintenance of the H3K27me3 repressive chromatin mark. Abnormal EZH2 expression has been associated with various cancers including breast cancer. Here, we discuss the contribution of EZH2 and the PRC2 complex in controlling the H3K27 methylation status and subsequent consequences on genomic instability and the cell cycle in breast cancer cells. We also discuss distinct molecular mechanisms used by EZH2 to suppress BRCA1 functions.
More Related Videos
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere
Master Transcription Regulators
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...